Pharmacology and mechanisms of action of new oral anticoagulants-Reference-Cited by-同舟云学术

Pharmacology and mechanisms of action of new oral anticoagulants

Published:2014-09-25 Issue:1 Volume:29 Page:10-20
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Salem Joe-Elie¹²³,Sabouret Pierre⁴,Funck-Brentano Christian¹²³,Hulot Jean-Sebastien¹²³

Affiliation:

1. Department of Pharmacology and UMR ICAN 1166; Faculty of Medicine; Institute of Cardiometabolism and Nutrition (ICAN); Sorbonne Universités; UPMC Univ Paris 06 F-75013 Paris France

2. Department of Pharmacology and CIC-1421; Institute of Cardiometabolism and Nutrition (ICAN); AP-HP; Pitié-Salpêtrière Hospital; F-75013 Paris France

3. INSERM; Institute of Cardiometabolism and Nutrition (ICAN); CIC-1421 and UMR ICAN 1166; F-75013 Paris France

4. Department of Cardiology; AP-HP; Pitié-Salpêtrière Hospital; F-75013 Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12091/fullpdf

Reference55 articles.

1. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty;Eriksson;N. Engl. J. Med.,2008

2. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty;Lassen;N. Engl. J. Med.,2008

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N. Engl. J. Med.,2009